Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma

Overview of attention for article published in Blood, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 74 X posts from 67 X users, with an upper bound of 111,969 followers.

RT @gloria_iacoboni: Published today in @BloodJournal 🎉 Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Trea…

RT @gloria_iacoboni: Published today in @BloodJournal 🎉 Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Trea…

RT @gloria_iacoboni: Published today in @BloodJournal 🎉 Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Trea…

RT @gloria_iacoboni: Published today in @BloodJournal 🎉 Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Trea…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 70 additional X posts.